Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CRS | NTNX |
|---|---|---|
| Price | $387.61 | $70.85 |
| Change today | ▼ 0.31% | ▲ 0.62% |
| Market cap | $19.21B | $19.17B |
| Return, 3 months | -36.4% | +38.4% |
| Return, year to date | +23.3% | +37.1% |
| Return, 1 year | +54.5% | -6.2% |
| P/E (TTM) | 36.8 | 13.7 |
| P/B | 8.6 | 27.3 |
| P/E percentile vs own 5y | 56th | 80th |
| Dividend yield | 0.21% | – |
| Revenue growth (YoY, latest qtr) | +12.6% | +15.9% |
| Net profit growth (YoY) | +45.4% | +3,184.9% |
| Gross margin | 30.6% | 86.8% |
| Operating margin | 22.5% | 9.6% |
| Net margin | 17.0% | 52.8% |
| Return on equity | 25.7% | 37,460.2% |
| Analyst target vs. price | +58.4% | +11.9% |
| Analyst buy share | 86% | 62% |
| RSI (14) | 26 | 63 |
| 30-day volatility | 30.8% | 28.7% |
| Max drawdown, 1 year | -37.8% | -56.0% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
